Disease Awareness Campaign By REALITYRx

Genzyme Disease Awareness Drive

Reality testing: Genzyme, a Sanofi Company, wanted to drive awareness of Pompe disease, a progressive and sometimes fatal disorder. The goal was to help accelerate diagnoses to optimize the management of the disease, by reaching a targeted audience and encouraging them to put Pompe disease into their differential diagnosis.

Envisioning a new reality: REALITYRx discovered that Pompe disease, which is considered difficult to diagnose because its symptoms overlap with numerous other neuromuscular diseases and conditions, could be more easily diagnosed, if suspected, by understanding its more prevalent signs and symptoms and by administering a simple blood test, which could help physicians rule it out earlier.

Inventing the reality: REALITYRx developed the “Needle in a Haystack” campaign to communicate the fact that, contrary to popular belief, when you know what you’re looking for, Pompe disease is easy to find.


Pompe Awareness Campaign

The Genzyme “Needle in a Haystack” campaign elevates awareness of Pompe disease so that it is more top-of-mind when physicians are diagnosing patients

Disease Awareness Website

This site has elevated the awareness of Pompe disease and is reigniting interest and the drive to achieve an earlier diagnosis

Exhibit Panels

A continuum of messages precisely conveys what physicians need to know to help distinguish Pompe disease from other common disorders


Telescoping Direct Mailer

Raises important questions and ultimately ties the queries together with the answer: Pompe disease can be more easily found and confirmed with a simple blood test

6-Panel Direct Mailers

With an average diagnostic delay of 9 years, raising awareness of the need to appropriately diagnose patients with Pompe disease is significant

Diagnostic Challenge

This program was developed using real-life cases and successfully challenges physicians to gain a greater understanding of how Pompe disease presents in patients




Genzyme Disease Awareness Drive

Reality testing: Genzyme, a Sanofi Company, wanted to drive awareness of Pompe disease, a progressive and sometimes fatal disorder. The goal was to help accelerate diagnoses to optimize the management of the disease, by reaching a targeted audience and encouraging them to put Pompe disease into their differential diagnosis.

Envisioning a new reality: REALITYRx discovered that Pompe disease, which is considered difficult to diagnose because its symptoms overlap with numerous other neuromuscular diseases and conditions, could be more easily diagnosed, if suspected, by understanding its more prevalent signs and symptoms and by administering a simple blood test, which could help physicians rule it out earlier.

Inventing the reality: REALITYRx developed the “Needle in a Haystack” campaign to communicate the fact that, contrary to popular belief, when you know what you’re looking for, Pompe disease is easy to find.


Pompe Awareness Campaign

The Genzyme “Needle in a Haystack” campaign elevates awareness of Pompe disease so that it is more top-of-mind when physicians are diagnosing patients

Disease Awareness Website

This site has elevated the awareness of Pompe disease and is reigniting interest and the drive to achieve an earlier diagnosis

Exhibit Panels

A continuum of messages precisely conveys what physicians need to know to help distinguish Pompe disease from other common disorders


Telescoping Direct Mailer

Raises important questions and ultimately ties the queries together with the answer: Pompe disease can be more easily found and confirmed with a simple blood test

6-Panel Direct Mailers

With an average diagnostic delay of 9 years, raising awareness of the need to appropriately diagnose patients with Pompe disease is significant

Diagnostic Challenge

This program was developed using real-life cases and successfully challenges physicians to gain a greater understanding of how Pompe disease presents in patients

Share This